Search Results
Site Search
Vector-borne diseases - Insights
Browse our full menu of individual tests and panels that aid in the diagnosis of vector-borne diseases.
A clearer path through a difficult diagnosis - Insights
The fourth episode of “Life of a Specimen” video series explores the diagnosis enabled by antibody testing on Joy Carol’s cerebrospinal cord fluid and how her test result illuminated a path forward.
Serving more than 60 countries, Mayo Clinic Laboratories is creating a new standard for global diagnostic testing, offering international clients a vast test menu, access to Mayo Clinic experts, superior customer service, and more.
Innovative bile acid malabsorption panel transforms gastrointestinal care - Insights
Mayo Clinic Laboratories has introduced a revolutionary diagnostic test for bile acid malabsorption, a significant contributor to chronic diarrhea. Developed by Dr. Michael Camilleri and Dr. Leslie Donato, this new bile acid malabsorption...
Mayo Clinic Laboratories works closely with group purchasing organizations (GPOs) and purchasing groups (PGs) to provide clients access to our esoteric tests and services, delivering solutions that drive efficiency.
The exponential increase in the number of diagnostic tests available to physicians (in dermatopathology as well as other medical specialties) can be overwhelming, according to a new multi-institutional study co-published in the Journal of...
Pathways Case Studies: February 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for February include the following sub-specialties: Clinical Informatics,...
Pathways Case Studies: April 2021 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for April include the following sub-specialties: Genitourinary Pathology,...
Membranoproliferative glomerulonephritis (MPGN) is a pattern of glomerular injury. Based on the etiology of MPGN, Drs. Sethi and Fervenza proposed a new histologic classification of MPGN into Ig/IC-mediated MPGN and complement-mediated...
The Secrets of Cryoprecipitate: A Blood Banking Process - Insights
In this month’s “Hot Topic,” Jessie Swanson and Michelle Soland from the Component Laboratory will discuss the process improvement that helped decrease the standard cryoprecipitate dosage and the positive impact it has on patients.
Mayo Clinic Laboratories’ comprehensive menu of genetic cardiovascular testing provides results that support gene-based strategies to manage inherited cardiovascular disease.
STAT testing is available on a limited basis for patients with a suspected or known inborn error of metabolism when there is an increased risk of illness or death due to metabolic decompensation or when testing will allow for emergent...
BioPharma Diagnostics - Insights
BioPharma Diagnostics bring Mayo Clinic quality and expertise to collaborative engagements with biopharma, diagnostic and biotech companies to support a range of services, including clinical trial development, assay development, research...
Focused lung panel informs the use of targeted cancer therapies - Insights
Ying-Chun Lo, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated lung panel can better guide clinical decision-making, particularly about targeted lung cancer therapies.
Epansive clinical test menu, including more than 3,500 CAP- and CLIA-accredited tests. In addition to offering the world’s most sophisticated specialty test menu, we provide access to research-grade tests, pathology services, and sponsored...
Accurate Kidney Stone Analysis - Insights
In this “Hot Topic,” Paul Jannetto, Ph.D., highlights Mayo Clinic Laboratories’ AI-augmented kidney stone test and discusses the proper procedures for collecting and processing kidney stones to provide accurate, cost-effective analysis of...
Mayo Clinic’s cardiac (CV) remote monitoring service uses the compact MoMe Kardia cardiac monitoring device that yields a continuous, 24/7 stream of a patient’s ECG and motion data, no matter their location. Any troubling or burgeoning...
Multiomics: A new model for identifying biomarkers to predict severe COVID-19 outcomes - Insights
In a groundbreaking study, Mayo Clinic investigators have developed a multiomic molecular method to predict clinical COVID-19 (SARS-CoV-2) outcomes better than traditional cytokines. Using a machine-learning-based prediction model, the team...
MayoComplete Next-Generation Sequencing: Oncology Subpanels - Insights
In this month's "Hot Topic," Kevin Halling, M.D., Ph.D., discusses new next generation sequencing testing for various tumor types and the rationale for the enhancements that were made; reviews gene additions that are now available in each...
Beyond the Test Result: Greg Widseth - Insights
Greg Widseth was suddenly hit by a rare disease that prompted his immune system to attack his brain cells, resulting in as many as 60 seizures a day. Special blood and spinal fluid tests developed by Mayo Medical Laboratories confirmed that...
Learn more about Mayo Clinic Laboratories testing for pregnancy loss, which can help determine causes and risk of recurrence for future pregnancies.
As part of Mayo Clinic’s Neuro-Oncology practice, the Division of Laboratory Genetics and Genomics tests about 50 brain tumors a week, and upwards of 1,500 brain tumors a year from all over the world.
Then and now: Upholding Mayo Clinic's core values - Insights
Part two of the 50th Anniversary series highlights how Mayo Clinic Laboratories has remained focused on our core values through support of Mayo Clinic’s three shields – integrated clinical practice, research, and education.
Lisa Brown, quality specialist for Mayo Clinic Laboratories customer service, explains working "behind the scenes" when a client calls Mayo Clinic Laboratories with an inquiry, that call is typically picked up within 20 seconds by an agent...
Genetic Testing for Inherited Cardiovascular Disorders - Insights
In this month's "Hot Topic," Linnea Baudhuin, Ph.D., discusses Mayo Clinic Laboratories’ up-to-date gene panel tests for cardiomyopathies and arrhythmias, connective tissue and vascular fragility disorders, dyslipidemias, and congenital...
Ingenuity, collaboration, and expertise create a game-changing COVID-19 test swab - Insights
A massive effort culminated in Mayo Clinic designing, testing and mass-manufacturing a 3D-printed mid-turbinate swab for COVID-19 testing.
Mayo Clinic has been recognized as the No. 1 gastroenterology and gastrointestinal surgery hospital in the nation by U.S. News & World Report every year since 1990. Backed by the experience and knowledge of more than 140 digestive disease...
What started as a persistent headache for Spencer Lodin soon devolved into slowed speech, seizures, and hallucinations, symptoms which stumped ER doctors into thinking he had meningitis or was suffering from psychosis. Finally, specialized...
A collaboration with Mayo Clinic BioPharma Diagnostics includes access to the neurologic disease testing capabilities of Mayo Clinic Laboratories. Our highly specialized neurology testing menu features more than 400 neurologist-backed...
Reclaiming her joy: Joy Carol - Insights
A tenacious fighter, Joy Carol never lost hope that a mysterious condition that had stripped her of her ability to move would be identified. Hope turned into reality when a Mayo Clinic Laboratories test identified the cause of her illness...
An inside look at the state-of-the-art supports enabling invention - Insights
A web of innovation within Mayo Clinic Laboratories links research and test development with clinical practice, enabling for some of the world’s most pioneering methodologies. Underpinning this innovation network are unique supports that...
Reclaiming strength and independence after rare cancer diagnosis: Alexa Lofaro - Insights
It’s been more than three years since a team of specialists and genetic testing by Mayo Clinic Laboratories helped pinpoint the cause of Alexa Lofaro’s failing health. And today, she says she continues to feel “so much better” than she did...
Enhanced technology safeguards patient specimens - Insights
Mayo Clinic's use of enhanced radio-frequency identification technology to track specimens from the clinical setting to the lab reduces the risk of errors and protects valuable — sometime irreplaceable — patient samples.
New high-resolution urine drug testing profile - Insights
Bringing together advanced testing technology, unparalleled expertise, and a patient-focused approach, Mayo Clinic Laboratories’ new high-resolution urine drug testing profile, ADMPU, evaluates for 22 drug classes including alcohol,...
The evolution of specimen accessioning and delivery - Insights
The last installment of our 50th Anniversary series explores how Mayo Clinic Laboratories pioneered best practices in the area of specimen accessioning and delivery.
Building the business of lab medicine - Insights
In part three of the 50th Anniversary series, Mayo Clinic Laboratories looks further outside the walls of Mayo Clinic. With the belief that the latest in diagnostic testing should be available to any patient, no matter where they are...
Autoimmune Neurology Testing - Mayo Clinic Laboratories
Recognized as a world leader in the diagnosis and treatment of autoimmune neurologic disorders, Mayo Clinic mounts unmatched resources for developing new diagnostic biomarkers and unique laboratory tests.
With the rise of next generation sequencing (NGS) technology, multigene panel testing is expanding so rapidly that clinical practice is racing to keep pace. And questions within genetic tests have expanded along with it, making definitive...
New tests launched in December - Insights
December 2021, Mayo Clinic Laboratories announced thirty new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
The birth of Mayo Clinic Laboratories: From tiny operation to international mainstay - Insights
In 1971, the Regional Laboratory, later to become Mayo Clinic Laboratories, was founded. For the first time in Mayo Clinic’s history, the institution would support the community practice of pathology for outside patients in the region and...
Heartbeats of gratitude: Scott Olson - Insights
In a quiet suburb outside of Minneapolis, Minnesota, an ordinary Saturday took a sudden and alarming turn for Scott Olson when he began experiencing symptoms of ventricular tachycardia. Central to the care and treatment he'd receive at Mayo...
Check out the second episode of “Life of a Specimen,” a video exploration of the complex path taken by patient samples through testing at Mayo Clinic Laboratories. In this episode, we hear about the quality processes and careful treatment...
Grounded in gratitude, embracing treatment with hope - Insights
The fifth episode of “Life of a Specimen” video series highlights Joy Carol’s treatment journey after Mayo Clinic Laboratories antibody testing identified a paraneoplastic autoimmune disorder as the cause of her life-threatening symptoms.
FISH testing helps detect unseen cancer cells: Shannon Camlek - Insights
On the brink of losing her battle with acute myeloid leukemia, Shannon Camlek arrived at Mayo Clinic as a last hope. Her chances didn’t look good, but with the help of specialized genetic testing, particularly FISH (fluorescence in situ...
Clinical microbiology at Mayo Clinic: A look back and ahead - Insights
The field of clinical microbiology has a long and distinguished history at Mayo Clinic. Since the early 1900s, the clinical microbiology team has played important and leading roles in advancing testing and patient care.
Update on 2021 WHO classification of lung tumors - Insights
In this month’s “Hot Topic,” Anja Roden, M.D., discusses new entities and changes of terminology in the 2021 World Health Organization (WHO) classification of lung tumors as well as the nomenclature in small biopsies.
Pathways Case Studies: March 2021 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for March include the following sub-specialties: Pulmonary Pathology, Cardiovascular...
Pathways Case Studies: February 2021 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for February include the following sub-specialties: Neuropathology,...
ACHE 2017 Congress on Healthcare Leadership Live Blog - Insights
Andy Cousin, FACHE, Director of Product Management and Marketing for Mayo Medical Laboratories, is attending this year's ACHE Congress on Health Care Leadership conference in Chicago. He will be sharing his thoughts and photos from the...
Pleural Mesothelioma - Insights
In this month's "Hot Topic," Anja Roden, M.D., a thoracic pathologist at Mayo Clinic, gives an update on the 2021 World Health Organization (WHO) classification and ancillary testing of pleural mesothelioma.